Moderna, Inc.

Historical 13F Holders

Symbol
MRNA
CUSIP
60770K107
All holders as of
Q4 2024
Type
Equity
Class
COM
Reported Value, Excluding Options
Total Filings
Period Filings Shares, Excl. Options Value, Excl. Options
2024 Q4 803 276 M $11.5 B
2024 Q3 870 261 M $17.4 B
2024 Q2 1,040 269 M $32.0 B
2024 Q1 983 272 M $29.0 B
2023 Q4 966 269 M $26.9 B
2023 Q3 974 247 M $25.9 B
2023 Q2 1,041 248 M $30.2 B
2023 Q1 1,097 273 M $38.5 B
2022 Q4 1,163 263 M $47.5 B
2022 Q3 1,002 248 M $29.3 B
2022 Q2 1,124 244 M $34.9 B
2022 Q1 1,111 251 M $43.2 B
2021 Q4 1,205 250 M $63.4 B
2021 Q3 1,238 243 M $93.5 B
2021 Q2 991 229 M $53.9 B
2021 Q1 852 210 M $27.4 B
2020 Q4 802 201 M $21.1 B
2020 Q3 626 206 M $14.5 B
2020 Q2 542 220 M $14.1 B
2020 Q1 334 196 M $5.88 B
2019 Q4 177 177 M $3.45 B
2019 Q3 151 169 M $2.69 B
2019 Q2 161 144 M $2.10 B
2019 Q1 115 138 M $2.80 B
2018 Q4 83 134 M $2.02 B